Gerresheimer AG (GXId)

86.32
-1.75(-2.00%)
  • Volume:
    6,080
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    85.45 - 87.45
  • Type:Equity
  • Market:Germany
  • ISIN:DE000A0LD6E6

GXId Overview

Prev. Close
87.65
Day's Range
85.45-87.45
Revenue
1.43B
Open
86.6
52 wk Range
82.14-103.7
EPS
-
Volume
6,080
Market Cap
2.68B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
17,766
P/E Ratio
-
Beta
-
1-Year Change
-9.18%
Shares Outstanding
31,400,000
Next Earnings Date
Oct 12, 2021
What is your sentiment on Gerresheimer AG?
or
Market is currently closed. Voting is open during market hours.

Gerresheimer AG News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellSellSellStrong SellBuy
Technical IndicatorsNeutralStrong SellStrong SellStrong SellSell
SummarySellStrong SellStrong SellStrong SellNeutral

Gerresheimer AG Company Profile

Gerresheimer AG Company Profile

Employees
10032
Market
Euro Zone

Gerresheimer AG, together with its subsidiaries, manufactures and sells specialty glass, plastic products, and drug delivery-devices and solutions primarily worldwide. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables, and components for dialysis machines, and catheters and surgical devices. It also provides containers for the delivery of tablets and powders, liquid dosages, ophthalmic and rhinological applications, parenteral packaging applications, oral prescription medications, and cosmetics. The Primary Packaging Glass division offers glass primary packaging for pharma and cosmetics industries, such as ampoules, cartridges, vials, syrup and dropper bottles, tablet jars, and wide-neck jars, as well as injection, infusion, and transfusion bottles; flacons and pots for fragrances, deodorants, and care and decorative cosmetics; and bottles and jars for spirits and food. The Advanced Technologies division develops drug delivery products and platforms, such as micro pumps, which are used to self-administer medication for heart failure or Parkinson’s for pharmaceutical and biotech customers. The company was founded in 1864 and is headquartered in Düsseldorf, Germany.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.